The FDA has been working for more than a dozen years to develop an effective way to warn consumers about the risk of liver damage in cases of acetaminophen overdose. In this week's Healthcare Packaging online it was announced that, "The FDA (has) issued a rule requiring new warnings on the labels of acetaminophen . . . warning about severe liver damage." According to the article, "manufacturers have to change their labels to comply by April 28, 2010." (See http://www.healthcare-packaging.com/newsletters/hcp-08-10-09.html)
One FDA suggestion was to eliminate over-the-counter combination products like cold remedies that contain decongestants, antihistamines AND acetaminophen. Double dosing occurs when a consumer takes a cold medicine for coughing/congestion then develops a headache and takes Tylenol. Apparently, the FDA has chosen to try new labeling first, since the economic impact of removing combination products would be considerable.
Source: www2.canada.com/montrealgazette, www.healthcare-packaging.com
One FDA suggestion was to eliminate over-the-counter combination products like cold remedies that contain decongestants, antihistamines AND acetaminophen. Double dosing occurs when a consumer takes a cold medicine for coughing/congestion then develops a headache and takes Tylenol. Apparently, the FDA has chosen to try new labeling first, since the economic impact of removing combination products would be considerable.
Source: www2.canada.com/montrealgazette, www.healthcare-packaging.com
